Current Edition


FDA rejects Insys opioid pain spray

Insys Therapeutics said Friday that the Food and Drug Administration issued it a Complete Response Letter rejecting the company’s New Drug Application for Buvaya. The …

Continue Reading →

FDA launches medical device ‘innovation challenge’ to combat opioid crisis

  The Food and Drug Administration announced Wednesday an “innovation challenge” aimed at encouraging the development of medical devices such as digital health applications and …

Continue Reading →